Skip to content

PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension

PVRI Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05329714
Acronym
PVRI GoDeep
Enrollment
40000
Registered
2022-04-15
Start date
2020-01-30
Completion date
2055-01-30
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Global Health, Pulmonary Hypertension

Keywords

Pulmonary Hypertension, Data Integration, Standardization, Global Health, Quality Indicators

Brief summary

PVRI-GoDeep is a PH Meta-Registry, run under the umbrella of the Pulmonary Vascular Research Institute (PVRI). It merges anonymized PH patient related data from various local registries around the world run under the responsibility of PVRI members. It will be operated under the auspices of the University of Giessen/Giessen PH center. Combining deep phenotyping with worldwide outreach, PVRI-GoDeep aims to offer insights into specific geographical and ethnical profiles of PH, to deepen the epidemiological, clinical and molecular understanding of this disease and to promote strategies for improved individualized treatment of PH patients.

Detailed description

PVRI-GoDeep is a PH Meta-Registry, run under the umbrella of the Pulmonary Vascular Research Institute (PVRI). It merges anonymized PH patient related data from various local registries around the world run under the responsibility of PVRI members. It will be operated under the auspices of the University of Giessen/Giessen PH center. Combining deep phenotyping with worldwide outreach, PVRI-GoDeep aims to offer insights into specific geographical and ethnical profiles of PH, to deepen the epidemiological, clinical and molecular understanding of this disease and to promote strategies for improved individualized treatment of PH patients. The data provided by PVRI-GoDeep will support academia to perform scientific projects in the field of PH. Pharmaceutical / commercial companies will be charged fee for access to PVRI-GoDeep data and / or analysis, thereby creating revenues exclusively devoted to support the PVRI mission and the registries entering their data into PVRI-GoDeep. All requests from academia or commercial companies are to be decided by the PVRI-GoDeep consortium, serving as Use and Access Committee.

Interventions

None listed

Sponsors

Imperial College London
CollaboratorOTHER
Johns Hopkins University
CollaboratorOTHER
Stanford University
CollaboratorOTHER
University of Sheffield
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
University of Pavia
CollaboratorOTHER
Hospital de Niños de la Santísima Trinidad
CollaboratorUNKNOWN
Academy of Medical Sciences of Ukraine
CollaboratorOTHER
The Methodist Hospital Research Institute
CollaboratorOTHER
Vanderbilt University Medical Center
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
National and Kapodistrian University of Athens
CollaboratorOTHER
Aristotle University Of Thessaloniki
CollaboratorOTHER
University Hospital of Targu Mures, Romania
CollaboratorOTHER
University Hospital Heidelberg
CollaboratorOTHER
Milpark Hospital
CollaboratorUNKNOWN
University of Minnesota
CollaboratorOTHER
Royal Prince Alfred Hospital, Sydney, Australia
CollaboratorOTHER
Fiona Stanley Hospital
CollaboratorOTHER
Sunshine Coast University Hospital
CollaboratorUNKNOWN
China-Japan Friendship Hospital
CollaboratorOTHER
Medical University of Graz
CollaboratorOTHER
National Hospital Organization Okayama Medical Center
CollaboratorOTHER
Royal Hobart Hospital
CollaboratorOTHER_GOV
University Hospital, Zürich
CollaboratorOTHER
Universidad Nacional de La Plata
CollaboratorOTHER
Gold Coast Hospital and Health Service
CollaboratorOTHER_GOV
University of Giessen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Clinical Diagnosis of Pulmonary Hypertension

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Global analysis of PH patientsFrom entry into the registry up to 10 yearsGlobal comparison and analysis of the course of disease of PH patients

Countries

Germany

Contacts

Primary ContactRaphael W Majeed
raphael.majeed@innere.med.uni-giessen.de+49 641 985 42502

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026